Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Medicine|June 20, 2022
A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE StudyChristian Dejaco, Thomas Mueller, Omid Zamani, et al.
Harm Reduction Journal|April 8, 2025
Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in IranMehrdad Khezri, Fatemeh Tavakoli, Soheil Mehmandoost, et al.
Journal of Epidemiology and Global Health|March 11, 2024
Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling LeishmaniasisMehdi Bamorovat, Iraj Sharifi, Ahmad Khosravi, et al.
The New England Journal of Medicine|March 31, 2016
Baricitinib in Patients with Refractory Rheumatoid ArthritisMark C Genovese, Joel Kremer, Omid Zamani, et al.
BMC Cancer|June 19, 2026
Effect of immunonutrition on surgery outcomes in cancer patients: evidence from an umbrella review on interventional and observational meta-analysesHelia Mardani, Ulduz Riazi Khameneh, Ali Jafari, et al.
Annals of the Rheumatic Diseases|October 16, 2012
Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) studyJoachim Sieper, Shankar Srinivasan, Omid Zamani, et al.
Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.
Frontiers in Public Health|May 15, 2023
Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination planIraj Sharifi, Ahmad Khosravi, Mohammad Reza Aflatoonian, et al.
Annals of the Rheumatic Diseases|May 21, 2013
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA studyDae Hyun Yoo, Pawel Hrycaj, Pedro Miranda, et al.
BMJ Open|April 15, 2026
Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025-2030Akbar Fotouhi, Sobhan Younesian, Seyede Maryam Mousavi, et al.
Pageof 2